DCF — BOZEMAN DEACONESS HEALTH SERVICES
Enterprise Value: $-793.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-793.9M
Enterprise Value
$-248.1M
PV of Cash Flows
$-545.7M
PV of Terminal Value
$-878.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $407.5M | $-51.1M | -13.0% | $-68.3M | $-62.1M |
| Year 2 | $419.7M | $-48.4M | -12.0% | $-66.2M | $-54.7M |
| Year 3 | $432.3M | $-45.6M | -11.0% | $-63.9M | $-48.0M |
| Year 4 | $445.3M | $-44.7M | -10.0% | $-63.5M | $-43.4M |
| Year 5 | $458.6M | $-44.9M | -10.0% | $-64.3M | $-39.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-793.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$395.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1303880834269352
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5